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Abstract
It is well known that the nephron endowment of healthy subjects is highly variable and that individual nephron mass has
potentially important implications both in health and disease. However, nephron count is technically impossible in living
subjects. Based on the observation of an increase in serum creatinine (sCr) in otherwise healthy newborns with solitary kidney
during the physiological perinatal dehydration, we hypothesized that perinatal sCr might be helpful in identifying healthy
subjects with a reduced nephron mass. In the framework of a study on blood pressure in babies (NeoNeph), sCr of normal
Caucasian neonates was determined 48–96 h after birth and their association with a family history of arterial hypertension (AH)
was analyzed. SCr was determined in 182 normal newborns (90 males) at a mean of 61 ± 8 h after birth (range 46–82). Newborns
with paternal AH had a higher mean sCr (0.97 + 0.28 mg/dL) then newborns without paternal AH (0.73 + 0.28 mg/dL; p =
0.006). No differences in mean sCr were found in relation with mother or grandparent’s history of AH.
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Conclusion: The association between parental AH and high sCr during perinatal dehydration supports the hypothesis that the
latter is a promising tool for identifying normal subjects with a reduced nephron mass with potential important implications in
prevention and in understanding the individual outcome of renal and extrarenal diseases (including AH).
What is Known:
• Nephron endowment of healthy subjects is highly variable and individual nephron mass has potentially important implications both in health and
disease however nephron count is not feasible in living subjects.
What is New:
• Serum creatinine during perinatal dehydration is a possible biomarker for identifying normal subjects with a reduced nephron mass.
Keywords Nephron endowment . Newborn . Arterial hypertension . Blood Pressure . Perinatal serum creatinine
Introduction
The concept of individual nephron endowment has potentially
important implications for both health and disease. The outcome
of renal diseases, the toxicity arising from drug exposure, and the
risk of arterial hypertension may all be very different depending
on the number of nephrons at birth given that the entire comple-
ment of the human kidney is determined by 36 weeks’ gestation,
and nephrons do not regenerate [6, 11, 20].
It is well known that the endowment of healthy subjects varies
widely from aminimumof a few hundred thousand nephrons per
kidney to a maximum of over two millions, although it is not
technically possible to count them except in the setting of a post-
mortem examination [7, 16–19, 22]. During physiological peri-
natal dehydration, the serum creatinine (sCr) levels of subjects
born with monolateral renal agenesis (who have fewer nephrons
by definition) are much higher than those observed in neonates
with two kidneys, but subsequently (even as early as the first
month of life), they become indistinguishable from those of the
general population [12, 21]. On the basis of this simple observa-
tion, we hypothesized that serum creatinine levels 48–72 h after
birth (when healthy babies usually reach the nadir of postnatal
body weight) might help to identify subjects with a reduced
nephron mass. On the other hand, a reduced number of nephron
and the consequent reduced capacity to excrete the common
excessive salt intake have been often related to salt-sensitive
hypertension which typically affects younger people [1]. We
therefore measured serum creatinine 2–4 days after delivery in
a series of newborns and evaluated its association with the family
history of arterial hypertension (AH).
Methods
After obtaining the informed consent of their parents/guard-
ians, healthy and appropriate for gestational age Caucasian
neonates born at term after an uneventful pregnacy (37–
41 weeks) underwent sCr determinations at the time of the
expanded newborn screening test. Birth weight, weight loss,
and family history of AH (parents and grandparents) were
recorded by means of an Bad hoc^ questionnaire. Exclusion
criteria were any mother’s disease or any pathological event
during pregnancy including need of medications, any proven
or suspected disease in the baby (all patients had performed
ECHO scan screening at 20th–22nd gestational week (GW))
including birth weight < 2500 or > 4400 g or premature birth
(< 37th GW) and supra-physiological perinatal dehydration
(> 13% of birth weight).
Blood samples were taken within 2–4 days after delivery. The
study was approved by the Ethics Committee of our Institution.
The determination of sCr, which was repeated at 1 year of age,
was performed by means of a LC-MS/MS validated method
from the dried blood spots normally used for newborn screening
[3, 5].
TheMann-Whitney test andmultiple linear regressionmodels
(with a robust standard error because of the slightly non-normal
distribution of sCr levels) were used to correlate sCr levels of
newborns with the family history of AH. The adjustment covar-
iates were gender of the newborn, absolute weight loss (grams),
and weight loss velocity (grams/h) between birth and the time of
blood sampling.
Analyses were performed using Stata 13 (StataCorp. 2013.
Stata: Release 13. Statistical Software. College Station, TX:
StataCorp LP).
Results
SCr levels were determined a mean 61 ± 8 h after birth (range
46–82) in 182 normal (90 males) Caucasian newborns whose
mean birth weight was 3301 ± 374 g (range 2495–4345). By the
time sCr was measured, their mean weight loss had been 253 ±
78 g (range 25–510), equivalent to a total mean weight loss of
7.7 ± 2.3% or a loss per hour of 0.13 ± 0.04% of their birth
weight (range 0.01–0.24).
The median sCr and interquartile range (IQR)), as determined
during perinatal dehydration, was 0.72 mg/dL (0.56–0.95) with-
out any significant difference by gender; its relation with family
history of AH is shown in detail in Table 1. The 11 newborns
with paternal AH, out of which 8 (73%)weremales, had a higher
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mean sCr level then newborns without paternal AH in either
crude (p = 0.005) or adjusted analysis (p = 0.006) (Fig. 1). No
differences in mean sCr levels were found in relation with
mother’s or grandparents’ history of AH, nor with the number
of affected parents/grandparents. The sCr level was redetermined
at 1 year of age and all values were within the normal range; in
detail, the median value was 0.34 (IQR 0.29–0.47) without any
correlation between the level recorded perinatally and 1 year
later. During the very first days of life, only 6% of the newborns
were exposed to formula feeding and the relative distributionwas
not different in those born to normotensive or hypertensive
fathers.
Discussion
In Western countries, approximately 7% of the general popu-
lation have moderate chronic kidney disease (CKD), and this
high frequency cannot be explained by immunological or ge-
netic diseases because they only affect less than 0.01% of the
populat ion. The most common cause of CKD is
nephroangiosclerosis, which is also responsible for one-third
of the cases of end-stage renal disease (ESRD). This condition
is due to the involvement of the kidney vasculature in the
atherogenic disease which, as correctly stated by Zoccali,
drives the high rate of cardiovascular morbidity in industrial-
ized countries [25]. The potential role of a reduced number of
nephrons in the increased risk of hypertension and its cardio-
vascular consequences, as well as in progressive kidney dis-
eases, has been clearly documented: rat strains with a large
number of nephrons are less susceptible to the development of
CKD, and conversely, a reduced number of nephrons are as-
sociated with hypertension and CKD [8, 10, 13, 14]. Back in
1988, Brenner et al. postulated that kidneys with fewer neph-
rons and a consequently small filtration surface area have less
sodium excretion capacity, thus inducing hypervolemia as a
consequence of high dietary sodium intake which can turn
into the development of hypertension [4]. In this theoretical
setting, the small number of nephrons is a condition that pre-
disposes to hypertension which, once developed, contributes
to damage other nephrons (nephroangiosclerosis), thus creat-
ing a vicious circle that leads to a further reduction in the
already limited number of nephrons and the development of
CKD and finally ESRD. Nowadays, it is known that a number
of metabolites that accumulate in the case of a reduced neph-
ron mass (such as phosphate, uric acid, parathyroid hormone,
fibroblast growth factor 23, and others) may be responsible for
vascular damage and thus further contribute to the spiral lead-
ing to ESRD and cardiovascular morbidity [23, 24].
Moreover, it can be presumed that subjects with fewer neph-
rons are more susceptible to the renal or systemic effects of
exogenous toxic agents (nephrotoxic drugs) and endogenous
(immunological) assault. The possibility of correlating a signif-
icant part of the different outcomes of these conditions with
differences in nephron endowment has not been extensively
explored because of the lack of reliable means of categorizing
subjects a priori, on the basis of their number of nephrons.
The rationale of the present study was based on the fre-
quent observation, by neonatal nephrologists, that otherwise
healthy subjects with unilateral renal agenesis, whose sCr
levels under normal conditions are well within the normal
range, are much more likely to show significantly higher
levels as a result of minor dehydration than subjects with
two kidneys. The same is true of patients with congenital
abnormalities of the kidney and urinary tract (CAKUT),
who have fewer nephrons because of renal hypodysplasia
[12, 21].
In addition to being intuitively consistent with the general
knowledge of renal physiology, our hypothesis that sCr levels
during physiological dehydration may reflect individual neph-
ron endowment is indirectly supported by the finding of a
significantly higher sCr level in neonates born to hypertensive
parents, given the well-documented concept that hypertension
Table 1 Mean (SD) serum creatinine levels during perinatal dehydra-
tion in 182 consecutive newborns according to arterial hypertension fam-
ily history
Family history of AH N* Mean (SD)
sCr (mg/dL)
Crude
p value**
Adjusted
p value***
Mother
Without AH 179 0.75 (0.29) 0.61 0.19
With AH 2 0.78 (0.01)
Father
Without AH 169 0.73 (0·28) 0.005 0.006
With AH 11 0.97 (0·28)
Maternal grandmother
Without AH 123 0.76 (0.28) 0.76 0.71
With AH 57 0.74 (0.31)
Maternal grandfather
Without AH 105 0.75 (0.27) 0.46 0.58
With AH 63 0.72 (0.30)
Paternal grandmother
Without AH 106 0.72 (0.26) 0.50 0.51
With AH 49 0.76 (0.29)
Paternal grandfather
Without AH 105 0.76 (0.31) 0.25 0.12
With AH 63 0.70 (0.28)
AH arterial hypertension, sCr serum creatinine
*Newborns with missing information on AH in the family not included
**From Mann-Whitney tests
***Frommultiple regressionmodels with robust standard error, including
the covariates gender of the newborn, absolute weight loss (grams), and
weight loss speed (grams/h) between birth and the time of blood sampling
Note: Conversion factors for units: serum creatinine inmg/dL to mol/L, ×
88 .4
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in younger subjects is associated with a reduced number of
nephrons in otherwise healthy young subjects [14, 15].
It is interesting that the association between blood pres-
sure in relatives and sCr during dehydration is observed in
children with hypertensive fathers only, not with hyperten-
sive mothers or grandparents. As far as mothers are con-
cerned, the number of subjects with AH was very small
(thus insufficient for statistical significance), perhaps be-
cause they were quite younger than fathers (34.7 ± 4.5 vs
37.2 ± 5.6 years; p < 0.001). Finally, it is known that arte-
rial hypertension of the elderly has a different ethiological
pattern (atherosclerosis) than that of young adults in whom
low nephron mass might be more relevant [2, 9].
We are aware that, being based on relatively small numbers
and on indirect evidences, our findings are preliminary but, to
the best of our knowledge, our hypothesis has never been
postulated before, and the possibility of identifying subjects
with a reduced number of nephrons very early in life and by
means of a simple test not only opens up a series of preventive
opportunities, but also allows for new interpretations
and speculations concerning important causes of mor-
bidity and their variable outcomes in the adult popula-
tion. The findings may also provide other researchers a
clue for a better understanding of disease mechanisms
and ways of promoting health. If they are confirmed
and extended with follow-up data tracking arterial blood
pressure in this and other cohorts of children, it might
be worth considering a neonatal screening program fo-
cused on the risk of CKD. All the metabolic diseases
for which a screening program is a standard of care in
many countries are much less common than hyperten-
sion, CKD and the consequent cardiovascular morbidity.
Another potential critical issue in the present study is the
use of sCr for estimating renal function which is perhaps not
the best biomarker in newborns for a number of possible in-
terferences (bilirubin, muscular mass, mother’s sCr, etc). This
choice, although questionable, was determined by the impos-
sibility of proposing venopuncture in a study setting on
healthy newborns which would not have been accepted by
parents. SCr determination on blood drop taken at time of
the metabolic screening was the only acceptable compromise.
Nevertheless, our main finding is based on comparison rather
than on absolute values, minimizing the potential bias (includ-
ing those derived from maternal sCr).
In conclusion, the association among parental AH and high
sCr during perinatal dehydration supports the hypothesis that
the latter is an interesting possible tool for identifying subjects
with a reduced nephron mass with potential important impli-
cations in understanding the individual outcome of renal dis-
eases (including drug toxicity), expanding our knowledge on
the pathophysiology of common renal and extrarenal diseases,
and providing clues for individualized preventive measures.
The physiological dehydration of newborns is a unique
event in which pure dehydration takes place without any con-
comitant confounding metabolic conditions that might inter-
fere with the interpretation of renal function adaptation.
Furthermore, the neonatal period is also unique in terms of
parental receptiveness to health promotion messages provided
that these are not generic but individualized to the specific
needs of their own children.
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Fig. 1 Perinatal serum creatinine during perinatal dehydration according to family history of arterial hypertension
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